G. J. Huchon (Paris, France), S. Ward (Glasgow, United Kingdom)
Exercise capacity, tidal expiratory flow limitation, and dyspnoea in patients with stable COPD
M. Kontogiorgi, E. N. Kosmas, E. Perraki, D. Bisirtzoglou, A. Koutsoukou, D. Orphanidou, J. Milic-Emili, N. G. Koulouris (Athens, Greece; Montreal, Canada)
|  |
Pulmonary hypertension and exercise capacity in patients with severe chronic obstructive pulmonary disease
K. Vonbank, G. Funk, R. Ziesche, V. Petkov, L. Stiebellehner, P. Schenk, P. Haber (Vienna, Austria)
| |
Encouraged six minute walking test reflects 'maximal' sustainable exercise performance in COPD patients
A. Casas, J. Vilaró, R. Rabinovich, A. F. Mayer, J. L. Valera, E. Bertoni, J. A. Barberà, R. Rodriguez-Roisin, J. Roca (Barcelona, Spain)
| |
Prognostic predictors for survival in patients with COPD using cardiopulmonary testing
T. Hiraga, R. Maekura (Toyonaka, Japan)
| |
d-ETCO2/d-VO2 is a useful index to evaluate exercise tolerance in COPD patients
S. Takata, M. Haraguchi, H. Shimizu, Y. Dairaku, M. Murata, R. Mitani, M. Kimura, M. Harada, M. Matsuzaki (Ube, Japan)
| |
Factors associated with improvement in breathing capacity during exercise in patients with chronic obstructive pulmonary disease (COPD)
K. C. Ong, Y. T. Wang (Singapore, Singapore)
| |
Exercise test results and forced expiratory flow rates at low lung volumes
P. Z. Imiolek (Sosnowiec, Poland)
| |
Ventilatory response to upper extremity exercise (UEx) in severe COPD patients
M. Sivori, C. Saenz (Buenos Aires, Argentina)
| |
Exercise testing in patients with COPD. VO2 measure in different tests
M. V. Lopez Varela, F. Gimenez, K. Fagundez (Montevideo, Uruguay)
| |
Comparison between six minute walking test and corresponding constant work rate treadmill exercise in COPD patients
S. Kostianev, V. Hodgev, B. Marinov (Plovdiv, Bulgaria)
| |
Physiological responses during four clinical exercise protocols in COPD patients
A. Casas, J. Vilaró, R. Rabinovich, A. F. Mayer, R. Antoneli, J. L. Valera, J. A. Barberà, R. Rodriguez-Roisin, J. Roca (Barcelona, Spain)
| |
Interval exercise as an alternative modality to continuous exercise in patients with severe COPD
I. Vogiatzis, S. Nanas, E. Kastanakis, O. Georgiadou, O. Papazahou, P. Rothitis, C. Roussos (Athens, Greece)
| |
Effects of eight weeks exercise training on functional capacity, ventilatory efficiency and quality of life in patients with chronic heart failure
S. Kostianev, M. Tokmakova, B. Dobreva (Plovdiv, Bulgaria)
| |
Influence of pulmonary rehabilitation on spontaneous cardiac baroreflex sensitivity in patients with COPD
F. Costes, F. Roche, V. Pichot, J. C. Barthelemy (St Etienne, France)
| |
Effects of long acting β2-agonist, sustained-release theophylline and their combination on exercise parameters in asthmatic patients
E. N. Kalmanova, Z. R. Aisanov (Moscow, Russia)
| |
Improvements with tiotropium on endurance measured by the shuttle walking test (SWT) and on health related quality of life (HRQoL) in COPD patients
G. Huchon, C. Verkindre, F. Bart, B. Aguilaniu, J. C. Guerin, C. Lemerre, P. Gineste (Paris, Bethune, Grenoble, Lyon, Nimes, Reims, France)
| |
Mechanisms of improved exercise tolerance in COPD in response to tiotropium
D. E. O'Donnell, H. Magnussen, F. Gerken, S. Kesten, T. Fluege (Kingston, Canada; Grosshansdorf, Ingelheim, Germany; Ridgefield, United States Of America)
| |
Long term oxygen therapy enhances endurance in patients with severe COPD, but moderate hypoxaemia and intermittent hypercapnia
P. Haidl, D. Köhler (Schmallenberg, Germany)
| |